Trial intelligence / Profile preview

FluvalAB Seasonal Influenza Vaccine Serologic Clinical Trial 2007-2008

2007-002614-19Phase 4Completed

Sponsor
Omninvest
Start
May 2007
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of FluvalAB in influenza, sponsored by Omninvest. Primary endpoints: Seroconversion rate in younger adults and Seroconversion rate in older adults. Started May 2007; status: completed.

02

Drugs

FluvalAB
03

Conditions

influenza

Beyond the preview

Go deeper on 2007-002614-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-002614-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call